Hints and tips:
Related Special Reports
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
...But Amyris had also branched out into being an incubator for beauty start-ups including Rose Inc, Costa Brazil and JVN hair care, and it proved too huge a leap from developing molecules to developing brands...
...“It has become a bigger company and this could create the perception that it needs more insurance,” said Kevin Lacroix, an attorney and executive vice-president at RT ProExec, a unit of RT Specialty, an...
...The case is one of many challenges the company has faced to what the Dutch Pharmaceutical Accountability Foundation calls its “goose with golden eggs”....
...Grail is selling Galleri to US consumers for about $950 as a “laboratory-developed test”, a category that does not require approval from the US Food and Drug Administration and is not widely reimbursed by...
...Dean Li, president of Merck Research Laboratories, said the positive trial findings represented an important milestone in the company’s collaboration with Moderna....
...It is seeking additional information from Merck and Abbott Laboratories to try to identify the loopholes and propose legislation to prevent tax avoidance....
...“We look forward to discussing these data with the scientific community and health authorities so we may rapidly introduce an Omicron-modified booster as soon as possible if authorised by regulators,” he...
...The outspoken Marcus, who is known to send all-caps emails late into the night, developed his own conviction about life sciences after he began representing early biotech companies seeking laboratory space...
...Merck, the US pharmaceutical group, is planning to build a £1bn UK hub including research laboratories on a prominent central London site opposite King’s Cross rail station....
...Jonathan Li, director of the Harvard/Brigham virology specialty laboratory in Boston, said it was “striking” that two variants of concern — Beta and Omicron — had arisen in southern Africa, a region with...
...That really needs to be made clear,” said Dr Leana Wen, an emergency physician and professor of health policy and management at George Washington University....
...Isomorphic Labs will partner with pharmaceutical and biomedical companies and is currently hiring scientists, engineers, and machine learning experts....
...Researchers from the Africa Health Research Institute reported that the loss of immune protection from the vaccine when it was pitted against Omicron was “extensive but incomplete” after analysing plasma...
...The research park’s own website says Alder is “a research laboratory focused on mycelium”....
...Axa IM Alts, a division of French fund group Axa Investment Managers, announced in July that it would spend almost €2bn on specialist laboratory space and offices in Europe, and private equity houses Blackstone...
...It said that existing evidence, a combination of laboratory tests and real-world studies, showed that its shot worked against a number of variants of concern, including Delta....
...The results gathered by Israel’s health ministry, and seen by the Financial Times, showed that the vaccine was 89 per cent effective at preventing infection of any kind and 94 per cent effective against...
...The companies said they were evaluating the vaccine against other strains, including one that first emerged in Brazil, and were conducting studies to monitor the vaccine’s effectiveness outside of the laboratory...
...The Covid-19 vaccine developed by BioNTech and Pfizer is likely to be effective against a rapidly spreading strain of the virus that was first discovered in the UK, a laboratory-based study by the companies...
...Covid-19 vaccines from Moderna and BioNTech/Pfizer have been shown to work against the B.1.1.7 variant in laboratory tests....
...Africa, according to a laboratory study....
...pharmaceutical sector and look with envy at the UK, Germany and the US....
...The Luxembourg-based freezer producer has more than tripled its normal annual production of 500 to 1,000 units, recording massive demand for its 700L unit, used in laboratories and hospitals, which can store...
International Edition